C4 Therapeutics, Inc. (CCCC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 158.33M |
| Enterprise Value | 143.71M |
| P/E Ratio | -3.44 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 10.86 |
| Price/Book Ratio | 1.82 |
| Enterprise/Revenue | 10.23 |
| Enterprise/EBITDA | -3.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.89 |
| Operating Margin | -3.19 |
AD
Management Effectiveness
| Return On Assets | -0.28 |
| Return On Equity | -0.45 |
Income Statement
| Revenue | 35.95M |
| Revenue/Share | 0.27 |
| Gross Profit | 27.97M |
| EBITDA | -102.91M |
| Net Income | -104.99M |
| Diluted EPS | -1.27 |
Balance Sheet
| Total Cash | 253.66M |
| Total Cash/Share | 1.94 |
| Total Debt | 56.86M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 5.45 |
| Book Value Per Share | 1.89 |
Price History
| 52-Week Change | 28.36 |
| 52-Week High | 5.17 |
| 52-Week Low | 1.69 |
| Moving Average 50 Days | 3.9 |
| Moving Average 200 Days | 3.05 |
Statistics
| Average Volume | 3.02M |
| Shares Outstanding | 110.57M |
| % Held by Institutions | 90.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
